Analysts expect Cogent Biosciences, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.15 M | 31.78 M | 56.04 M | 50.01 M | 54.41 M | 174.79 M | 213.21 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.11 M | 29.16 M | 47.87 M | 41.47 M | 45.47 M | 147.62 M | 197.81 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.63 M | 30.47 M | 51.96 M | 45.74 M | 49.94 M | 161.21 M | 205.51 M |
Analysts expect Cogent Biosciences, Inc. to report earnings per share of -0.58 for Q3 26, against a range of -0.61 to -0.55. The most recent reported quarter, Q2 26, came in at -0.52, a 8.8% beat against the -0.57 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.64 | -0.61 | -0.64 | -0.53 | -0.50 | -0.60 | -0.53 | -0.52 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.51 | -0.61 | -0.57 | -0.57 | -0.47 | -0.55 | -0.47 | -0.54 | -0.55 | -0.54 | -0.43 | -0.39 | -0.35 | -0.36 | 0.15 | 0.27 | ||||||||||
| Low Estimate | -0.57 | -0.67 | -0.67 | -0.67 | -0.51 | -0.65 | -0.55 | -0.60 | -0.61 | -0.64 | -0.51 | -0.41 | -0.41 | -0.40 | 0.13 | 0.23 | ||||||||||
| Consensus Estimate | -0.54 | -0.64 | -0.62 | -0.62 | -0.49 | -0.60 | -0.51 | -0.57 | -0.58 | -0.59 | -0.47 | -0.40 | -0.38 | -0.38 | 0.14 | 0.25 |
Pull Wall Street consensus for Cogent Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=COGT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "COGT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=COGT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();